Member Info for TopCatz

https://kalkinemedia.com/uk/news/featured-news/tekcapital-addresses-the-growing-relevance-of-intellectual-property-for-business

We know most of this but this section on Lucyd is news to me

Additionally, Lucyd has exclusively licensed its IP to Innovative Eyewear Inc., which will be manufacturing and marketing Lucyd products globally.

Not sure what the deal is with Eyewear or how big Eyewear are globally but money for nothing. It's either based on royalties or a flat rate licence. Something to chew the cud over

Hi Philbatch - I consider Bellescura as most likely to come in so if it does and no other news has dropped on the other companies I would bail at around 30p. If other news has dropped first on one of the other companies and we are talking about a higher SP bass i'd probably top slice on wait for the Bellescura news. Just my take but will review along the way

Charts point to 30p but hard to value traditionally - Obviously if they list we can work it out from there but the FDA approval will come first so very hard to guage. Guident should be releasing news in the non to distant too by all accounts.

Hi all - Serious question to long term holders. Considering TEK's cut in Bellascura (without the buy in option) who would like to share their valuations on FDA approval.

Regards
TC

Off on Holidays tomorrow. Looking forward to returning to an Sp much further North than where we are now :) Enjoy the sunshine and switch off. This will do the business in it's own sweet time.

Good luck all

I agree Meddler. Whilst TEK is a bit of wild beast and hard to predict if you draw a line up through the low point on the day we got the news that FDA approval had been delayed until H2 you can clearly see we are skirting along, just above that line so good place to buy. Range is 10p-15p until something comes along to rerate (up or down)

Just to be clear that's 15p is OHR as of today. Not that it will be there by 4.30pm (wouldn't say no though)

15p today and rising with no news. If it starts moving up there (and TEK can do a few pence in a few days no sweat with very little buying) then we know there's a decent RNS in the pipleline. Will need something positive to break 15p

Wasn't thinking Sale personally Astrad but if it does happen we'll all be minted imo. We can dream

I love the way the carrot is dangling with this one. Expect an update within 60 days (I'd imagine there is a lot of slack there as they don't want to look stupid after Bellescura missed their deadline for FDA approval. Can't see much selling going on before the Guident update/news lands. Hopefull news from somewhere else beforehand so we can smash through 15p and then we're on our way with a decent head of wind. Happy to be in

Needless to say they have been pretty negative over the last couple of weeks. They're on the turn now and the MACD which is signalling a buy on the yearly (been a few months since that was positive) so at these levels this is a BUY. Main resistance to breach will be in the region of 14.5p and rising daily. Would be good to be there or there abouts when the next news breaks. I imagine we will because buying ALWAYS proceeds news. Good luck all. Reasons to be cheerful :)

Morning Feeks

Yes, looks like they will put up a recording of the conference call, Q & A's etc and it will be accessible for 7 days. Pretty standard practice so assuming they do what they say they are in line.

I get you Steve. I'm just clueless as to what takes precedence and what effect that might have etc. Let s hope that all becomes clear on Monday.

I will be disappointed if someone can't shine a light on what's going on and put it to bed

edit -
cleaner should read clear

Hi Steveiom. I'm getting a bit confused here : Below is the primary outcome measure as detailed in your link for the study, but we already know the FDA wanted 15 units so i'm not sure if this is relevant, ie they weren't going to pass it whatever happened. It's certainly not cleaner and definitely something that i think could be explained in a bit more detail without giving away any price sensitive information at the AGM. Here's hoping anyway.

Ability to correctly assemble and use the X-PLO2R POC [ Time Frame: 2 hours ]
A subject who is able to follow the instructions to correctly assemble and receive oxygen through the X-PLO2R POC will be considered a study pass.A subject who is not able to follow the instructions and does not correctly assemble and receive oxygen through the X-PLO2R POC will be considered a study fail.

Nice one TL - I emailed TEK IR but got no reply. I sent them my address but i'm not expecting to see a packet. Minor detail (i'd rather see an higher SP haha) but good to hear you got a sample and that they do indeed exist :)

Yes TL - The pandemic has done very few companies a favour. I still think we will get a progress report on the day itself as a precursor to Q & A's etc. It will just be a broad outline on progress and will give us a flavour (no pun intended). There probably won't be anything in there that's going to set the SP alight because that information would be issued via an RNS. However it makes perfect sense to hold on to any progress reports just in case. Here's hoping

They only started distributing in May so I think you may be expecting a little too much, too soon for Salarius but of course any information is priceless. Most see the Salarius potential being a contract with a major snack distributor purely for the salt imho

That will be the last you hear from the FCA then !

Maybe we'll get an update (progress only I imagine unless something timely drops) on the other products tomorrow, Friday and Monday am.

That's what I would do if I wanted to avoid any poor communication criticism at the agm.